Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Amortization of Deferred Charges (2019 - 2026)

Wave Life Sciences filings provide 8 years of Amortization of Deferred Charges readings, the most recent being $1.5 million for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 13.58% to $1.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.6 million, a 13.53% increase, with the full-year FY2025 number at $5.4 million, up 13.53% from a year prior.
  • Amortization of Deferred Charges hit $1.5 million in Q1 2026 for Wave Life Sciences, up from $1.4 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.5 million in Q1 2026 to a low of $784000.0 in Q1 2022.
  • Median Amortization of Deferred Charges over the past 5 years was $1.1 million (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Amortization of Deferred Charges: soared 75.27% in 2022 and later rose 10.68% in 2023.
  • Wave Life Sciences' Amortization of Deferred Charges stood at $983000.0 in 2022, then grew by 12.0% to $1.1 million in 2023, then rose by 13.44% to $1.2 million in 2024, then rose by 13.53% to $1.4 million in 2025, then rose by 3.24% to $1.5 million in 2026.
  • The last three reported values for Amortization of Deferred Charges were $1.5 million (Q1 2026), $1.4 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.